Table 2.
Patients | Clinicians | Regulators§ | HTDs | EU – HTA | |
---|---|---|---|---|---|
Population | C | C (important) | C (optional) | I (evt C) | R* |
Intervention | I (optional) | I | n/a | A/R | I |
Comparator | C | C (important) | C (optional) | I (evt C) | R* |
Outcomes | C (Important) | C (important) | C (optional) | I (evt C) | R* |
Note: *: HTA bodies are consulted (C) during the development phase; accountability (A) resides with national HTA bodies. §: For the regulatory approval process, regulators are A/R throughout the process which is creating the frame for EU HTA to operate. evt: eventually.